280 related articles for article (PubMed ID: 18350399)
41. Effects of exercise training and montelukast in children with mild asthma.
Bonsignore MR; La Grutta S; Cibella F; Scichilone N; Cuttitta G; Interrante A; Marchese M; Veca M; Virzi' M; Bonanno A; Profita M; Morici G
Med Sci Sports Exerc; 2008 Mar; 40(3):405-12. PubMed ID: 18379200
[TBL] [Abstract][Full Text] [Related]
42. Effect of montelukast on polymorphonuclear leukocyte functions in asthmatic patients.
Gürer US; Büyüköztürk S; Palandüz S; Gürbüz B; Cevikbaş A
Int Immunopharmacol; 2003 Sep; 3(9):1257-60. PubMed ID: 12890423
[TBL] [Abstract][Full Text] [Related]
43. Effects of oral montelukast on airway function in acute asthma.
Cýllý A; Kara A; Ozdemir T; Oğüş C; Gülkesen KH
Respir Med; 2003 May; 97(5):533-6. PubMed ID: 12735671
[TBL] [Abstract][Full Text] [Related]
44. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
[TBL] [Abstract][Full Text] [Related]
45. [Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome].
Di Rienzo L; Artuso A; Cerqua N
Acta Otorhinolaryngol Ital; 2000 Oct; 20(5):336-42. PubMed ID: 11284261
[TBL] [Abstract][Full Text] [Related]
46. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients.
Boskabady MH; Javan H; Sajady M; Rakhshandeh H
Fundam Clin Pharmacol; 2007 Oct; 21(5):559-66. PubMed ID: 17868210
[TBL] [Abstract][Full Text] [Related]
47. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma.
Lambiase A; Bonini S; Rasi G; Coassin M; Bruscolini A; Bonini S
Arch Ophthalmol; 2003 May; 121(5):615-20. PubMed ID: 12742837
[TBL] [Abstract][Full Text] [Related]
48. [Successful and effective: Montelukast in clinical practice].
Internist (Berl); 1999 Dec; 40(12 Suppl Montelukas):1-4. PubMed ID: 10635479
[No Abstract] [Full Text] [Related]
49. Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children.
Pedersen S; Agertoft L; Williams-Herman D; Kuznetsova O; Reiss TF; Knorr B; Dass SB; Wolthers OD
Pediatr Pulmonol; 2007 Sep; 42(9):838-43. PubMed ID: 17659605
[TBL] [Abstract][Full Text] [Related]
50. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
51. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Lu S; Liu N; Dass SB; Reiss TF
J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
[TBL] [Abstract][Full Text] [Related]
52. Airway obstruction lability helps distinguish levels of disease activity in asthma.
Greenberg S; Liu N; Kaur A; Lakshminarayanan M; Zhou Y; Nelsen LM; Smugar SS; Noonan G; Reiss TF; Knorr BA
Respir Med; 2012 Apr; 106(4):500-7. PubMed ID: 22301379
[TBL] [Abstract][Full Text] [Related]
53. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
Kopriva F; Dzubak P; Potesil J; Hajduch M
J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
[TBL] [Abstract][Full Text] [Related]
54. Effect of montelukast on quality of life in subjects with nasal polyposis accompanying bronchial asthma.
Yazıcı ZM; Sayın I; Bozkurt E; Kayhan FT
Kulak Burun Bogaz Ihtis Derg; 2011; 21(4):210-4. PubMed ID: 21762051
[TBL] [Abstract][Full Text] [Related]
55. Churg Strauss syndrome during treatment of bronchial asthma with a leucotriene receptor antagonist presenting with polyneuropathy.
Oberndorfer S; Beate U; Sabine U; Peter H; Heinz L; Barabra H; Wolfgang G
Neurologia; 2004 Apr; 19(3):134-8. PubMed ID: 15088164
[TBL] [Abstract][Full Text] [Related]
56. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
[TBL] [Abstract][Full Text] [Related]
57. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
[No Abstract] [Full Text] [Related]
58. Improvement of otitis media with effusion after treatment of asthma with leukotriene antagonists in children with co-existing disease.
Balatsouras DG; Eliopoulos P; Rallis E; Sterpi P; Korres S; Ferekidis E
Drugs Exp Clin Res; 2005; 31 Suppl():7-10. PubMed ID: 16444906
[TBL] [Abstract][Full Text] [Related]
59. [Clinical benefits of montelukast sodium treatment in chronic adult asthma].
Trofor A; Rascarachi G; Popa E; Chiseliţă I
Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):298-302. PubMed ID: 12638278
[TBL] [Abstract][Full Text] [Related]
60. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma.
Telleria JJ; Blanco-Quiros A; Varillas D; Armentia A; Fernandez-Carvajal I; Jesus Alonso M; Diez I
Respir Med; 2008 Jun; 102(6):857-61. PubMed ID: 18339529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
